Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC
Condition: Staging IV NSCLC Intervention: Drug: Rh-endostatin Sponsor: Guangzhou Institute of Respiratory Disease Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials